Your browser doesn't support javascript.
loading
Simulating the Impacts of Augmenting Intensive Vector Control with Mass Drug Administration or Test-and-Treat Strategies on the Malaria Infectious Reservoir.
Nankabirwa, Joaniter I; Arinaitwe, Emmanuel; Briggs, Jessica; Rek, John; Rosenthal, Philip J; Kamya, Moses R; Olwoch, Peter; Smith, David L; Rodriguez-Barraquer, Isabel; Dorsey, Grant; Greenhouse, Bryan.
Afiliación
  • Nankabirwa JI; Department of Internal Medicine, Makerere University College of Health Sciences, Kampala, Uganda.
  • Arinaitwe E; Infectious Disease Research Collaboration, Kampala, Uganda.
  • Briggs J; Infectious Disease Research Collaboration, Kampala, Uganda.
  • Rek J; Department of Infectious Diseases, School of Medicine, University of California, San Francisco, California.
  • Rosenthal PJ; Infectious Disease Research Collaboration, Kampala, Uganda.
  • Kamya MR; Department of Infectious Diseases, School of Medicine, University of California, San Francisco, California.
  • Olwoch P; Department of Internal Medicine, Makerere University College of Health Sciences, Kampala, Uganda.
  • Smith DL; Infectious Disease Research Collaboration, Kampala, Uganda.
  • Rodriguez-Barraquer I; Infectious Disease Research Collaboration, Kampala, Uganda.
  • Dorsey G; Department of Health Metrics Sciences, University of Washington, Seattle, Washington.
  • Greenhouse B; Department of Infectious Diseases, School of Medicine, University of California, San Francisco, California.
Am J Trop Med Hyg ; 107(5): 1028-1035, 2022 11 14.
Article en En | MEDLINE | ID: mdl-36191870
ABSTRACT
Highly effective vector control can reduce malaria burden significantly, but individuals with parasitemia provide a potential reservoir for onward transmission. We performed an empirical, non-parametric simulation based on cohort data from Tororo District, Uganda-an area with historically high but recently reduced malaria transmission-to estimate the effects of mass drug administration (MDA) and test-and-treat on parasite prevalence. We estimate that a single round of MDA would have accelerated declines in parasite prevalence dramatically over 2 years (cumulative parasite prevalence ratio [PPR], 0.34). This decline was mostly during the first year of administration (PPR, 0.23) and waned by 23 months (PPR, 0.74). Test-and-treat using a highly sensitive diagnostic had nearly the same effect as MDA at 1 year (PPR, 0.27) and required many fewer treatments. The impact of test-and-treat using a standard diagnostic was modest (PPR, 0.58 at 1 year). Our analysis suggests that in areas experiencing a dramatic reduction in malaria prevalence, MDA or test-and-treat with a highly sensitive diagnostic may be an effective way of reducing or eliminating the infectious reservoir temporarily. However, for sustained benefits, repeated rounds of the intervention or additional interventions are required.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Malaria Falciparum / Malaria / Antimaláricos Tipo de estudio: Diagnostic_studies / Prevalence_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Africa Idioma: En Revista: Am J Trop Med Hyg Año: 2022 Tipo del documento: Article País de afiliación: Uganda

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Malaria Falciparum / Malaria / Antimaláricos Tipo de estudio: Diagnostic_studies / Prevalence_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Africa Idioma: En Revista: Am J Trop Med Hyg Año: 2022 Tipo del documento: Article País de afiliación: Uganda